検索結果

Overseas Activities | SENJU Pharmaceutical

. As we enter the era of globalization, our overseas activities are now diverse. In addition to the export of finished products, the licensing of product technologies and patents exceeds 50 countries....

お知らせ | 千寿製薬株式会社

June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（

Presence of Products | Overseas Activities | SENJU Pharmaceutical

Asia Middle East Europe North&South Ameica Asia Korea Brand Name Marketing Authorisation Holder JP Brand Name BRONUCK Taejoon Pharmaceutical Co., Ltd. BRONUCK ALYMUS Taejoon Pharmaceutical Co., Lt

お知らせ | 千寿製薬株式会社

Management Policy | About Senju | SENJU Pharmaceutical

arch and development ability This vision shows our determination to continue creating and providing excellent pharmaceutical products and services that care for the five main sensory functions (eyesig...